WINNERS & LOSERS: Time Finance backs buyout; Nostrum sells assets
(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Monday. Read More
| Price | 3.60p on 07-09-2026 at 05:00:08 |
|---|---|
| Change | 0.00p 0% |
| Buy | 0.00p |
| Sell | 0.00p |
| Last Trade: | Unknown 602.00 at 3.60p |
| Day's Volume: | 0 |
| Last Close: | 3.60p |
| Open: | 0.00p |
| ISIN: | GB0033711010 |
| Day's Range | 0.00p - 0.00p |
| 52wk Range: | 3.30p - 19.00p |
| Market Capitalisation: | £22.46m |
| VWAP: | 0.00p |
| Shares in Issue: | 623.91m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Immupharma (IMM) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Unknown* | 602 | 3.60p | OTC Trade |
16:35:03 - 04-Sep-26 |
| Sell* | 603 | 3.60p | Uncrossing Trade |
16:35:03 - 04-Sep-26 |
| Sell* | 5,000 | 3.625p | Ordinary |
16:28:52 - 04-Sep-26 |
| Sell* | 18,415 | 3.625p | Ordinary |
16:27:49 - 04-Sep-26 |
| Buy* | 2,531 | 3.755p | Ordinary |
16:21:50 - 04-Sep-26 |
| Sell* | 25,600 | 3.6579p | Ordinary |
16:04:58 - 04-Sep-26 |
| Buy* | 62,852 | 3.755p | Ordinary |
15:49:09 - 04-Sep-26 |
| Sell* | 56,000 | 3.605p | Automatic Execution |
15:35:16 - 04-Sep-26 |
| Sell* | 150,000 | 3.69p | Ordinary |
15:28:40 - 04-Sep-26 |
| Sell* | 22,245 | 3.6999p | Ordinary |
15:26:10 - 04-Sep-26 |
Immupharma (IMM) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 10th Aug 2026 7:00 am | RNS | Bioanalytical CRO partner for Kapiglucagon |
| 22nd Jul 2026 7:00 am | RNS | Thermo Fisher CDMO selected for Kapiglucagon pro |
| 25th Jun 2026 1:20 pm | RNS | 2026 RESULT OF ANNUAL GENERAL MEETING |
| 25th Jun 2026 7:00 am | RNS | ImmuPharma appoints Bachem for Kapiglucagon API |
| 24th Jun 2026 7:00 am | RNS-R | University of Murcia research relating to P140 |
| 4th Jun 2026 7:10 am | RNS-R | Incanthera plc – Corporate Update & Board Changes |
| 2nd Jun 2026 7:00 am | RNS | Notice of AGM & Annual Report & Accounts |
| 27th May 2026 7:00 am | RNS | Final Results |
| 5th May 2026 7:00 am | RNS | IMM initiatesIND-Enabling Program for Kapiglucagon |
| 10th Apr 2026 7:00 am | RNS | Holding(s) in Company |